Porocarcinoma: an epidemiological, clinical, and dermoscopic 20-year study.

This study, with 52 patients with 53 tumors covering a follow-up period of more than 5 years, shows a less aggressive behavior of PC with 4% local recurrence, 6% nodal metastases, and 2% mortality.